Novartis Reveals Phase III GCAptAIN Trial Outcomes: Cosentyx Misses Primary Target for Giant Cell Arteritis image
2 min read

Novartis Reveals Phase III GCAptAIN Trial Outcomes: Cosentyx Misses Primary Target for Giant Cell Arteritis

Pharm'Up
Novartis has disclosed the preliminary findings from its Phase III GCAptAIN study, assessing Cosentyx® (secukinumab) for the...
Read More Read more about Novartis Reveals Phase III GCAptAIN Trial Outcomes: Cosentyx Misses Primary Target for Giant Cell Arteritis
Lupin and Zentiva Forge Strategic Partnership for Global Commercialization of Certolizumab Pegol Biosimilar image
2 min read

Lupin and Zentiva Forge Strategic Partnership for Global Commercialization of Certolizumab Pegol Biosimilar

Pharm'Up
Lupin Limited, a global pharmaceutical leader, and Zentiva Group, a prominent pan-European pharmaceutical company, announced a landmark...
Read More Read more about Lupin and Zentiva Forge Strategic Partnership for Global Commercialization of Certolizumab Pegol Biosimilar
FDA Accepts Milestone Pharma’s CRL Response for CARDAMYST Nasal Spray; PDUFA Date Set for December 2025 image
2 min read

FDA Accepts Milestone Pharma’s CRL Response for CARDAMYST Nasal Spray; PDUFA Date Set for December 2025

Pharm'Up
Milestone Pharmaceuticals Inc. has announced that the U.S. Food and Drug Administration (FDA) has officially accepted its...
Read More Read more about FDA Accepts Milestone Pharma’s CRL Response for CARDAMYST Nasal Spray; PDUFA Date Set for December 2025

Read These Too

Pharmup 21
2 min read

Navigating Balance Disorders: Causes, Symptoms, and Management

Pharm'Up
Pharmup 20
1 min read

Understanding Seasonal Allergic Rhinitis: Causes, Symptoms, and Relief

Pharm'Up
Pharmup 19
1 min read

Pharmacovigilance Specialist Opportunity at Bausch + Lomb

Pharm'Up
Pharmup 18
1 min read

Career Opportunity: Formulation & Development (Injectable) at Derren Healthcare

Pharm'Up